The DOI matches its Crossref record; 88 of the 89 references it cites were found in a registry or an index.
Artificial intelligence in COVID-19 drug repurposing
Open accessAbstract
Drug repurposing or repositioning is a technique whereby existing drugs are used to treat emerging and challenging diseases, including COVID-19. Drug repurposing has become a promising approach because of the opportunity for reduced development timelines and overall costs. In the big data era, artificial intelligence (AI) and network medicine offer cutting-edge application of information science to defining disease, medicine, therapeutics, and identifying targets with the least error. In this Review, we introduce guidelines on how to use AI for accelerating drug repurposing or repositioning, for which AI approaches are not just formidable but are also necessary. We discuss how to use AI models in precision medicine, and as an example, how AI models can accelerate COVID-19 drug repurposing. Rapidly developing, powerful, and innovative AI and network medicine technologies can expedite therapeutic development. This Review provides a strong rationale for using AI-based assistive tools for drug repurposing medications for human disease, including during the COVID-19 pandemic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In some cases, these AI-powered approaches have been able to identify promising drug candidates in a fraction of the time that it would take when using traditional methods [26,27,28,29,30,31].”
From The role of AI in drug discovery: challenges, opportunities, and strategies (2023) · cites this paper as [28]
In the citing paper
“ML algorithms have been used to analyze large datasets of potential compounds and identify those with the most potential for treating the virus.”
From The role of AI in drug discovery: challenges, opportunities, and strategies (2023) · cites this paper as [28]
In the citing paper
“The study is a strong proof for the use of AI-assisted tools for drugs and repayment for human diseases, including COVID-19 in times of fatal disease [11].”
From Influential Usage of Big Data and Artificial Intelligence in Healthcare (2021) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
Learning representations by back-propagating errors
Rumelhart, D. E., Hinton, G. E., & Williams, R. J. (1986) · Nature · doi:10.1038/323533a0 · Cited by 31,892
The central role of the propensity score in observational studies for causal effects
ROSENBAUM, P. R., & RUBIN, D. B. (1983) · Biometrika · doi:10.1093/biomet/70.1.41 · Cited by 31,241
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report
Horby, P., Lim, W. S., Emberson, J., Mafham, M., Bell, J., Linsell, L., Staplin, N., Brightling, C., Ustianowski, A., Elmahi, E., et al. (2020) · doi:10.1101/2020.06.22.20137273 · Cited by 11,475
I.—COMPUTING MACHINERY AND INTELLIGENCE
TURING, A. M. (1950) · Mind · doi:10.1093/mind/lix.236.433 · Cited by 10,290
Remdesivir for the Treatment of Covid-19 — Final Report
Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007764 · Cited by 7,267
Computing Machinery and Intelligence (1950)
Turing, A. M. (2004) · doi:10.1093/oso/9780198250791.003.0017 · Cited by 6,120
(2013) · Cited by 5,726
LINE: Large-scale Information Network Embedding
Tang, J., Qu, M., Wang, M., Zhang, M., Yan, J., & Mei, Q. (2015) · Proceedings of the 24th International Conference on World Wide Web · doi:10.1145/2736277.2741093 · Cited by 5,416
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405
The trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360
Extrapulmonary manifestations of COVID-19
Gupta, A., Madhavan, M. V., Sehgal, K., Nair, N., Mahajan, S., Sehrawat, T. S., Bikdeli, B., Ahluwalia, N., Ausiello, J. C., Wan, E. Y., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0968-3 · Cited by 3,185
Proceedings of the 23rd international conference on Machine learning
Cohen, W. W., & Moore, A. (2006) · Cited by 2,647
Convolutional 2D Knowledge Graph Embeddings
Dettmers, T., Minervini, P., Stenetorp, P., & Riedel, S. (2018) · Proceedings of the AAAI Conference on Artificial Intelligence · doi:10.1609/aaai.v32i1.11573 · Cited by 2,486
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
Sanders, J. M., Monogue, M. L., Jodlowski, T. Z., & Cutrell, J. B. (2020) · JAMA · doi:10.1001/jama.2020.6019 · Cited by 2,392
Real-World Evidence — What Is It and What Can It Tell Us?
Sherman, R. E., Anderson, S. A., Pan, G. J. D., Gray, G. W., Gross, T. P., Hunter, N. L., LaVange, L. M., Marinac‐Dabic, D., Marks, P. W., Robb, M. A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmsb1609216 · Cited by 2,192
Complex Embeddings for Simple Link Prediction
Trouillon, T., Welbl, J., Riedel, S., Gaussier, É., & Bouchard, G. (2016) · arXiv · doi:10.48550/arxiv.1606.06357 · Cited by 2,100
Liu, J., Cao, R., Xu, M., Wang, X., Zhang, H., Hu, H., Li, Y., Hú, Z., Zhong, W., & Wang, M. (2020) · Cell Discovery · doi:10.1038/s41421-020-0156-0 · Cited by 2,091
Genomewide Association Study of Severe Covid-19 with Respiratory Failure
The Severe Covid-19 GWAS Group (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2020283 · Cited by 1,979
Hoffmann, M., Kleine-Weber, H., & Pöhlmann, S. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.04.022 · Cited by 1,852
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Zhou, Y., Hou, Y., Shen, J., Huang, Y., Martin, W., & Cheng, F. (2020) · Cell Discovery · doi:10.1038/s41421-020-0153-3 · Cited by 1,623
Federated Learning for Healthcare Informatics
Xu, J., Glicksberg, B. S., Su, C., Walker, P., Bian, J., & Wang, F. (2021) · Journal of Healthcare Informatics Research · doi:10.1007/s41666-020-00082-4 · Cited by 1,542
Federated Learning for Healthcare Informatics
Xu, J., Glicksberg, B. S., Su, C., Walker, P., Bian, J., & Wang, F. (2019) · arXiv · doi:10.48550/arxiv.1911.06270 · Cited by 1,538
Self-citationGenerating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks
Segler, M. H. S., Kogej, T., Tyrchan, C., & Waller, M. P. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00512 · Cited by 1,537
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
Richardson, P., Griffin, I., Tucker, C., Smith, D., Oechsle, O., Phelan, A., Rawling, M., Savory, E., & Stebbing, J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30304-4 · Cited by 1,456
Remdesivir for the Treatment of Covid-19 — Preliminary Report
Gillenwater, S., Rahaghi, F., & Hadeh, A. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2022236 · Cited by 1,422
RotatE: Knowledge Graph Embedding by Relational Rotation in Complex Space
Sun, Z., Deng, Z.-H., Nie, J.-Y., & Tang, J. (2019) · arXiv · doi:10.48550/arxiv.1902.10197 · Cited by 1,414
Häyrinen, K., Saranto, K., & Nykänen, P. (2008) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2007.09.001 · Cited by 1,374
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Goldman, J. D., Lye, D. C. B., Hui, D. S., Marks, K. M., Bruno, R., Montejano, R., Spinner, C. D., Galli, M., Ahn, M.-Y., Nahass, R. G., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2015301 · Cited by 1,362
Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir
Yin, W., Mao, C., Luan, X., Shen, D.-D., Shen, Q., Su, H., Wang, X., Zhou, F., Zhao, W., Gao, M., et al. (2020) · Science · doi:10.1126/science.abc1560 · Cited by 1,219
Rosenberg, E. S., Dufort, E. M., Udo, T., Wilberschied, L. A., Kumar, J., Tesoriero, J. M., Weinberg, P., Kirkwood, J., Muse, A., DeHovitz, J. A., et al. (2020) · JAMA · doi:10.1001/jama.2020.8630 · Cited by 1,174
George, H., Duke Jon, D., Shah Nigam, H., Reich Christian, G., Vojtech, H., Schuemie Martijn, J., Suchard Marc, A., Woong, P. R., Kei, W. I. C., Rijnbeek Peter, R., et al. (2015) · Studies in Health Technology and Informatics · doi:10.3233/978-1-61499-564-7-574 · Cited by 1,107
Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
Mancia, G., Rea, F., Ludergnani, M., Apolone, G., & Corrao, G. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2006923 · Cited by 1,087
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
Reynolds, H. R., Adhikari, S., Pulgarin, C., Troxel, A. B., Iturrate, E., Johnson, S. B., Hausvater, A., Newman, J. D., Berger, J. S., Bangalore, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2008975 · Cited by 1,068
Chong, C. R., & Sullivan, D. J. (2007) · Nature · doi:10.1038/448645a · Cited by 996
Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2)
Murphy, S. N., Weber, G. M., Mendis, M., Gainer, V. S., Chueh, H. C., Churchill, S. E., & Kohane, I. S. (2010) · Journal of the American Medical Informatics Association · doi:10.1136/jamia.2009.000893 · Cited by 926
Improving propensity score weighting using machine learning
Lee, B. K., Lessler, J., & Stuart, E. A. (2009) · Statistics in Medicine · doi:10.1002/sim.3782 · Cited by 920
Network-based prediction of drug combinations
Cheng, F., Kovács, I. A., & Barabási, A.-Ĺ. (2019) · Nature Communications · doi:10.1038/s41467-019-09186-x · Cited by 819
Beck, B. R., Shin, B., Choi, Y., Park, S., & Kang, K. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.03.025 · Cited by 815
Ramamoorthy, S., & Cidlowski, J. A. (2016) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.08.002 · Cited by 692
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
Jeon, S., Ko, M., Lee, J., Choi, I., Byun, S. Y., Park, S., Shum, D., & Kim, S. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00819-20 · Cited by 675
Launching PCORnet, a national patient-centered clinical research network
Fleurence, R., Curtis, L. H., Califf, R. M., Platt, R., Selby, J. V., & Brown, J. S. (2014) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2014-002747 · Cited by 654
Dyall, J., Coleman, C. M., Hart, B. J., Venkataraman, T., Holbrook, M. R., Kindrachuk, J., Johnson, R. F., Olinger, G. G., Jahrling, P. B., Laidlaw, M., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03036-14 · Cited by 653
Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond
Ghofrani, H. A., Osterloh, I. H., & Grimminger, F. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2030 · Cited by 632
Aliper, A., Plis, S., Artemov, A., Ulloa, A., Mamoshina, P., & Zhavoronkov, A. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00248 · Cited by 610
Network-based approach to prediction and population-based validation of in silico drug repurposing
Cheng, F., Desai, R. J., Handy, D. E., Wang, R., Schneeweiss, S., Barabási, A.-L., & Loscalzo, J. (2018) · Nature Communications · doi:10.1038/s41467-018-05116-5 · Cited by 552
How artificial intelligence is changing drug discovery
Fleming, N. (2018) · Nature · doi:10.1038/d41586-018-05267-x · Cited by 546
Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2
Hoffmann, M., Mösbauer, K., Hofmann-Winkler, H., Kaul, A., Kleine‐Weber, H., Krüger, N., Gassen, N. C., Müller, M. A., Drosten, C., & Pöhlmann, S. (2020) · Nature · doi:10.1038/s41586-020-2575-3 · Cited by 476
Stang, P. E., Ryan, P. B., Racoosin, J. A., Overhage, J. M., Hartzema, A. G., Reich, C., Welebob, E., Scarnecchia, T., & Woodcock, J. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-9-201011020-00010 · Cited by 441
New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis
Hou, Y., Zhao, J., Martin, W., Kallianpur, A. R., Chung, M. K., Jehi, L. E., Sharifi, N., ERZURUM, S. C., Eng, C., & Cheng, F. (2020) · BMC Medicine · doi:10.1186/s12916-020-01673-z · Cited by 436
Using deep learning to model the hierarchical structure and function of a cell
Ma, J., Yu, M. K., Fong, S., Ono, K., Sage, E., Demchak, B., Sharan, R., & Ideker, T. (2018) · Nature Methods · doi:10.1038/nmeth.4627 · Cited by 435
Target identification among known drugs by deep learning from heterogeneous networks
Zeng, X., Zhu, S., Lu, W., Liu, Z., Huang, J., Zhou, Y., Fang, J., Huang, Y., Guo, H., Li, L., et al. (2020) · Chemical Science · doi:10.1039/c9sc04336e · Cited by 357
Lenselink, E. B., ten Dijke, N., Bongers, B., Papadatos, G., van Vlijmen, H. W. T., Kowalczyk, W., IJzerman, A. P., & van Westen, G. J. P. (2017) · Journal of Cheminformatics · doi:10.1186/s13321-017-0232-0 · Cited by 334
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates
Maisonnasse, P., Guedj, J., Contreras, V., Behillil, S., Solas, C., Marlin, R., Naninck, T., Pizzorno, A., Lemaître, J., Gonçalves, A., et al. (2020) · Nature · doi:10.1038/s41586-020-2558-4 · Cited by 331
The $2.6 Billion Pill — Methodologic and Policy Considerations
Avorn, J. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500848 · Cited by 322
Ge, Y., Tian, T., Huang, S., Wan, F., Li, J., Li, S., Wang, X., Yang, H., Hong, L., Wu, N., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00568-6 · Cited by 300
Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning
Zeng, X., Song, X. H., Ma, T., Pan, X., Zhou, Y., Hou, Y., Zhang, Z., Li, K., Karypis, G., & Cheng, F. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00316 · Cited by 261
Interpretable Drug Target Prediction Using Deep Neural Representation
Gao, K. Y., Fokoue, A., Luo, H., Iyengar, A., Dey, S., & Zhang, P. (2018) · International Joint Conference on Artificial Intelligence · doi:10.24963/ijcai.2018/468 · Cited by 247
Greene, J. A., & Loscalzo, J. (2017) · New England Journal of Medicine · doi:10.1056/nejmms1706744 · Cited by 213
Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets
Park, S.-J., Yu, K.-M., Kim, Y., Kim, S.-M., Kim, E.-H., Kim, S.-G., Kim, E. J., Casel, M. A. B., Rollon, R., Jang, S., et al. (2020) · mBio · doi:10.1128/mbio.01114-20 · Cited by 186
Zhou, Y., Hou, Y., Shen, J., Mehra, R., Kallianpur, A., Culver, D. A., Gack, M. U., Farha, S., Zein, J., Comhair, S., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000970 · Cited by 180
Self-citationGe, Y., Tian, T., Huang, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.11.986836 · Cited by 168
Visible Machine Learning for Biomedicine
Yu, M. K., Ma, J., Fisher, J., Kreisberg, J. F., Raphael, B. J., & Ideker, T. (2018) · Cell · doi:10.1016/j.cell.2018.05.056 · Cited by 162
Supervised patient similarity measure of heterogeneous patient records
Sun, J., Wang, F., Hu, J., & Edabollahi, S. (2012) · ACM SIGKDD Explorations Newsletter · doi:10.1145/2408736.2408740 · Cited by 149
AI-powered drug discovery captures pharma interest
Smalley, E. (2017) · Nature Biotechnology · doi:10.1038/nbt0717-604 · Cited by 149
Ethics and governance for digital disease surveillance
Mello, M. M., & Wang, C.-H. J. (2020) · Science · doi:10.1126/science.abb9045 · Cited by 147
Nussinov, R., Jang, H., Tsai, C., & Cheng, F. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006658 · Cited by 134
Publisher Correction: Network-based prediction of drug combinations
Cheng, F., Kovács, I. A., & Barabási, A.-L. (2019) · Nature Communications · doi:10.1038/s41467-019-09692-y · Cited by 131
Sosa, D. N., Derry, A., Guo, M. G., Wei, E., Brinton, C., & Altman, R. B. (2019) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789811215636_0041 · Cited by 110
Network medicine framework for identifying drug-repurposing opportunities for COVID-19
Morselli Gysi, D., do Valle, Í., Zitnik, M., Ameli, A., Gan, X., Varol, O., Ghiassian, S. D., Patten, J. J., Davey, R. A., Loscalzo, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025581118 · Cited by 107
Randomized Clinical Trials and COVID-19
Bauchner, H., & Fontanarosa, P. (2020) · JAMA · doi:10.1001/jama.2020.8115 · Cited by 106
GraphVite: A High-Performance CPU-GPU Hybrid System for Node Embedding
Zhu, Z., Xu, S., Tang, J., & Qu, M. (2019) · International World Wide Web Conference (WWW) · doi:10.1145/3308558.3313508 · Cited by 104
Cong, Y., Hart, B. J., Gross, R., Zhou, H., Frieman, M. B., Bollinger, L., Wada, J., Hensley, L. E., Jahrling, P. B., Dyall, J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194868 · Cited by 98
Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing
Fang, J., Pieper, A. A., Nussinov, R., Lee, G., Bekris, L. M., Leverenz, J. B., Cummings, J. L., & Cheng, F. (2020) · Medicinal Research Reviews · doi:10.1002/med.21709 · Cited by 96
Meyer, J. G., Liu, S., Miller, I. J., Coon, J. J., & Gitter, A. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00236 · Cited by 92
Martin, W. R., & Cheng, F. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00397 · Cited by 66
Sosa, D. N., Derry, A., Guo, M. G., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/727925 · Cited by 61
Cheng, F., Murray, J. L., Zhao, J., Sheng, J., Zhao, Z., & Rubin, D. H. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005074 · Cited by 58
Wiseman, L. R., & Goa, K. L. (1997) · Drugs · doi:10.2165/00003495-199754010-00014 · Cited by 55
Mehta, H. B., Ehrhardt, S., Moore, T. J., Segal, J. B., & Alexander, G. C. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-039978 · Cited by 54
Healthcare in the Age of Interoperability: The Promise of Fast Healthcare Interoperability Resources
Braunstein, M. L. (2018) · IEEE Pulse · doi:10.1109/mpul.2018.2869317 · Cited by 53
Linden, A., & Yarnold, P. R. (2016) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12610 · Cited by 31
Convolutional 2D Knowledge Graph Embeddings
Dettmers, T., Minervini, P., Stenetorp, P., & Riedel, S. (2017) · arXiv · doi:10.48550/arxiv.1707.01476 · Cited by 30
Cheng, F., Rao, S., & Mehra, R. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87a.ccc037 · Cited by 26
Thalidomide maintenance in multiple myeloma
Laubach, J. P., Richardson, P. G. G., & Anderson, K. C. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.131 · Cited by 12
Wallach, I., Dzamba, M., & Heifets, A. (2015) · arXiv · doi:10.48550/arxiv.1510.02855
Cited by
Sorted by citations
The role of AI in drug discovery: challenges, opportunities, and strategies
Blanco-González, A., Cabezón, A., Seco-González, A., Conde-Torres, D., Antelo-Riveiro, P., Piñeiro, Á., & Garcia-Fandino, R. (2023) · Pharmaceuticals · doi:10.3390/ph16060891 · Cited by 690
The Ethics of Artificial Intelligence
Floridi, L. (2023) · doi:10.1093/oso/9780198883098.001.0001 · Cited by 682
Artificial intelligence in drug development
Zhang, K., Yang, X., Wang, Y., Yu, Y., Huang, N., Li, G. L., Li, X., Wu, J. C., & Yang, S. (2025) · Nature Medicine · doi:10.1038/s41591-024-03434-4 · Cited by 585
“An advanced pipeline has been created that integrates multimodal datasets, generates molecular leads using AI, ranks them by efficacy and safety, and uses deep reinforcement learning to create patentable analogs for testing 212 .”
Building a knowledge graph to enable precision medicine
Chandak, P., Huang, K., & Zitnik, M. (2023) · Scientific Data · doi:10.1038/s41597-023-01960-3 · Cited by 522
Artificial intelligence in cancer target identification and drug discovery
You, Y., Lai, X., Pan, Y. F., Zheng, H., Vera, J., Liu, S., Deng, S., & Zhang, L. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00994-0 · Cited by 499
“The key to identify therapeutic targets and discover drugs using ML-based biology analysis is to make use of network features in biological networks.”
BackgroundMethod
Metadata
- Authors
- Zhou, Y., Wang, F., Tang, J., Nussinov, R., & Cheng, F.
- Affiliations
- Cleveland Clinic (US)
- Cornell University (US)
- HEC Montréal (CA)
- Tel Aviv University (IL)
- Corresponding author
- Cheng, Feixiong
- Venue
- The Lancet Digital Health
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 2
- Issue
- 12
- Pages
- e667-e676
- ISSN
- 2589-7500 (ISSN-L)
- PMC
- PMC7500917
- OpenAlex
- W3087156149
- Cited by
- 636
- References
- 89
- Citations by year
- 2026: 50 · 2025: 74 · 2024: 73 · 2023: 131 · 2022: 117 · 2021: 173 · 2020: 18
- FWCI
- 9.64
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- The Lancet Digital Health (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- reponame:Expeditio Repositorio Institucional UJTL
- Funders
- National Science Foundation (2027970, 1750326, HHSN261200800001E)
- Cleveland Clinic
- Frederick National Laboratory for Cancer Research (HHSN261200800001E.)
- National Institutes of Health (#HHSN261200800001E, COVID-19, HHSN261200800001C)
- National Institute on Aging (R01AG066707)
- National Heart, Lung, and Blood Institute (R00HL138272, HHSN261200800001E)
- Office of Naval Research (N00014-18-1-2585, N00014)
- National Cancer Institute (HHSN261200800001E))
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › COVID-19 diagnosis using AI
- Keywords
- drug repurposing, COVID-19 pandemic, artificial intelligence, network medicine, precision medicine, drug target identification, drug development acceleration, big data
- MeSH terms
- SARS-CoV-2, COVID-19 Drug Treatment, Algorithms, Antiviral Agents, Artificial Intelligence, Drug Therapy, Combination, Humans, Treatment Outcome, Drug Discovery, Drug Repositioning
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
